Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dean G Karalis

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Advances in Therapy|December 17, 2016
A Review of Clinical Practice Guidelines for the Management of Hypertriglyceridemia: A Focus on High Dose Omega-3 Fatty AcidsDean G Karalis
Journal of Clinical Lipidology|July 20, 2020
Are statins safe in patients with COVID-19?Dean G Karalis
Atherosclerosis|September 22, 2014
Achieving optimal lipid goals in the metabolic syndrome: a global health problemDean G Karalis
Mayo Clinic Proceedings|April 3, 2009
Intensive lowering of low-density lipoprotein cholesterol levels for primary prevention of coronary artery diseaseDean G Karalis
Trends in Cardiovascular Medicine|September 8, 2020
Editorial commentary: Advances in the management of dyslipidemia: The future is bright, but what we do today is what matters mostDean G Karalis
Clinical Cardiology|September 12, 2007
The role of lipid-lowering therapy in preventing coronary heart disease in patients with type 2 diabetesDean G Karalis
Preventive Cardiology|October 6, 2007
The role of advanced lipid testing in clinical practiceDean G Karalis
Current Opinion in Lipidology|August 18, 2023
Strategies of improving adherence to lipid-lowering therapy in patients with atherosclerotic cardiovascular diseaseDean G Karalis
Current Atherosclerosis Reports|April 2, 2025
The Role of Non-Statin Lipid Lowering Therapies to Reduce ASCVD Events in Primary PreventionChukwuemezie Kamanu, Dean G Karalis
Current Atherosclerosis Reports|November 25, 2024
Statin Therapy for Primary and Secondary Prevention in Older AdultsAlicia Bao, Dean G Karalis
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Advances in Therapy|December 17, 2016
A Review of Clinical Practice Guidelines for the Management of Hypertriglyceridemia: A Focus on High Dose Omega-3 Fatty AcidsDean G Karalis
Journal of Clinical Lipidology|July 20, 2020
Are statins safe in patients with COVID-19?Dean G Karalis
Atherosclerosis|September 22, 2014
Achieving optimal lipid goals in the metabolic syndrome: a global health problemDean G Karalis
Mayo Clinic Proceedings|April 3, 2009
Intensive lowering of low-density lipoprotein cholesterol levels for primary prevention of coronary artery diseaseDean G Karalis
Trends in Cardiovascular Medicine|September 8, 2020
Editorial commentary: Advances in the management of dyslipidemia: The future is bright, but what we do today is what matters mostDean G Karalis
Clinical Cardiology|September 12, 2007
The role of lipid-lowering therapy in preventing coronary heart disease in patients with type 2 diabetesDean G Karalis
Preventive Cardiology|October 6, 2007
The role of advanced lipid testing in clinical practiceDean G Karalis
Current Opinion in Lipidology|August 18, 2023
Strategies of improving adherence to lipid-lowering therapy in patients with atherosclerotic cardiovascular diseaseDean G Karalis
Current Atherosclerosis Reports|April 2, 2025
The Role of Non-Statin Lipid Lowering Therapies to Reduce ASCVD Events in Primary PreventionChukwuemezie Kamanu, Dean G Karalis
Current Atherosclerosis Reports|November 25, 2024
Statin Therapy for Primary and Secondary Prevention in Older AdultsAlicia Bao, Dean G Karalis
Pageof 5